Mark A. Robinson

Array ( [id] => 7712115 [patent_doc_number] => 20120004282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA)' [patent_app_type] => utility [patent_app_number] => 13/256170 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 43918 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937703 [patent_doc_number] => 20110213007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'MicroRNAs and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/661801 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15750 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213007.pdf [firstpage_image] =>[orig_patent_app_number] => 12661801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070230 [patent_doc_number] => 20110045080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Single-Walled Carbon Nanotube/Bioactive Substance Complexes and Methods Related Thereto' [patent_app_type] => utility [patent_app_number] => 12/731021 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13723 [patent_no_of_claims] => 121 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045080.pdf [firstpage_image] =>[orig_patent_app_number] => 12731021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731716 [patent_doc_number] => 20120015026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING A DRUG AND SIRNA' [patent_app_type] => utility [patent_app_number] => 13/258919 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5671 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015026.pdf [firstpage_image] =>[orig_patent_app_number] => 13258919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538678 [patent_doc_number] => 20100204306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Method of Treating Neurodegenerative Disease' [patent_app_type] => utility [patent_app_number] => 12/725337 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 36524 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204306.pdf [firstpage_image] =>[orig_patent_app_number] => 12725337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858780 [patent_doc_number] => 08461315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'MicroRNAs and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/661041 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18550 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12661041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712130 [patent_doc_number] => 20120004290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'TREATING CHRONIC FATIGUE SYNDROME AND PROLONGED QT INTERVAL' [patent_app_type] => utility [patent_app_number] => 13/256039 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4584 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645198 [patent_doc_number] => 20100227911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/717511 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 75124 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227911.pdf [firstpage_image] =>[orig_patent_app_number] => 12717511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10168234 [patent_doc_number] => 09198927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-01 [patent_title] => 'Targeting opposite strand replication intermediates of single-stranded viruses by RNAI' [patent_app_type] => utility [patent_app_number] => 12/714949 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22151 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6009088 [patent_doc_number] => 20110061120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'SELF-CLEAVING RIBOZYMES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/715104 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22135 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20110061120.pdf [firstpage_image] =>[orig_patent_app_number] => 12715104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778271 [patent_doc_number] => 20120040906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PROTEIN TARGETS IN DISEASE' [patent_app_type] => utility [patent_app_number] => 13/202482 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5202 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040906.pdf [firstpage_image] =>[orig_patent_app_number] => 13202482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656503 [patent_doc_number] => 20110305772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR EX VIVO HEPATIC NUCLEIC ACID DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/203618 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19226 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305772.pdf [firstpage_image] =>[orig_patent_app_number] => 13203618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433200 [patent_doc_number] => 20100152279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma' [patent_app_type] => utility [patent_app_number] => 12/712323 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8456 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152279.pdf [firstpage_image] =>[orig_patent_app_number] => 12712323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754592 [patent_doc_number] => 20120027753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'MicroRNAs in Never-Smokers and Related Materials and Methods' [patent_app_type] => utility [patent_app_number] => 13/202666 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16036 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027753.pdf [firstpage_image] =>[orig_patent_app_number] => 13202666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241150 [patent_doc_number] => 20120149888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'SYNTHESIS OF ARA-2\'-O-METHYL-NUCLEOSIDES, CORRESPONDING PHOSPHORAMIDITES AND OLIGONUCLEOTIDES INCORPORATING NOVEL MODIFICATIONS FOR BIOLOGICAL APPLICATION IN THERAPEUCTICS, DIAGNOSTICS, G- TETRAD FORMING OLIGONUCLEOTIDES AND APTAMERS' [patent_app_type] => utility [patent_app_number] => 13/138465 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 24817 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13138465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670207 [patent_doc_number] => 20110319476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF' [patent_app_type] => utility [patent_app_number] => 13/201260 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29107 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447514 [patent_doc_number] => 20100144843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'RNAI THERAPEUTIC FOR RESPIRATORY VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/705463 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 53818 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144843.pdf [firstpage_image] =>[orig_patent_app_number] => 12705463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247415 [patent_doc_number] => 20100136678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'METHODS OF DIAGNOSIS OF SPINAL MUSCULAR ATROPHY AND TREATMENTS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/704204 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8261 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136678.pdf [firstpage_image] =>[orig_patent_app_number] => 12704204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054093 [patent_doc_number] => 20120076788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/148870 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14746 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076788.pdf [firstpage_image] =>[orig_patent_app_number] => 13148870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8245047 [patent_doc_number] => 08202974 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Synthetic RNA-based agonists of TLR7' [patent_app_type] => utility [patent_app_number] => 12/703612 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13393 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 375 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202974.pdf [firstpage_image] =>[orig_patent_app_number] => 12703612 [rel_patent_id] =>[rel_patent_doc_number] =>)